Concepedia

Marco M. Gottardis

MM

Statistics

Publications

112

Citations

8.5K

H-Index

52

Active since

1983

Affiliations

Bristol-Myers Squibb (United States)(Current)

Bristol-Myers Squibb (Germany)

Ligand Pharmaceuticals (United States)

The University of Texas MD Anderson Cancer Center

University of Wisconsin Carbone Cancer Center

Marco M. Gottardis is an author at Bristol-Myers Squibb (United States) specializing in medicine, pharmacology, and oncology.

ORCID

Publications per year

1983–2023

112

Publications

112

Contrasting actions of tamoxifen on endometrial and breast tumor growth in the athymic mouse.

Marco M. Gottardis, Simon P. Robinson, P.G. Satyaswaroop et al. · PubMed · 1988 · 423 citations

, , +15

Phosphorylated Insulin-Like Growth Factor-I/Insulin Receptor Is Present in All Breast Cancer Subtypes and Is Related to Poor Survival

Jennifer Law, Golareh Habibi, Kaiji Hu et al. · Cancer Research · 2008 · 408 citations · Full text

, , +14

Effect of cadmium on estrogen receptor levels and estrogen-induced responses in human breast cancer cells

Pilar García-Morales, Miguel Saceda, Nicholas Kenney et al. · Journal of Biological Chemistry · 1994 · 327 citations · Full text

, , +16

Insulin-Mediated Acceleration of Breast Cancer Development and Progression in a Nonobese Model of Type 2 Diabetes

Ruslan Novosyadlyy, Danielle E. Lann, Archana Vijayakumar et al. · Cancer Research · 2010 · 285 citations · Full text

, , +17

BMS-754807, a small molecule inhibitor of insulin-like growth factor-1R/IR

Joan M. Carboni, Mark D. Wittman, Zheng Yang et al. · Molecular Cancer Therapeutics · 2009 · 281 citations · Full text

, , +16

1–5 of 112